Your Skin Is Showing Your Arteries

Opening Scene

He came in for a routine echocardiogram follow-up, and while I was reviewing the images, he mentioned something almost in passing.

“My wife thinks I look older than I did last year. She’s not wrong. My skin has changed. More lines. My forehead looks different. I saw a dermatologist last month and she said to use sunscreen.” He said the last sentence with the tone men use when they have been told to do something they consider irrelevant.

He was fifty-one. Former military, currently senior logistics management, never smoked, exercised three days a week. His echo showed mildly reduced left ventricular diastolic function. Not alarming. Worth monitoring. His ApoB had been climbing: 124 mg/dL at his last draw, up from 109 two years prior. His coronary calcium score, which I had ordered the previous year at his insistence, was 98. Not nothing.

I looked at him then the way I had been trained to look at patients before we had any of these tools, the way my mentors called the clinical eye. What I noticed was not the lines. It was a diagonal crease, faint but present, in the lobule of his left earlobe. And faint yellowish deposits at the inner corners of both upper eyelids.

I stopped the visit.

“Before we talk about sunscreen,” I told him, “I want to talk about what I’m seeing in your face.”

Frank’s sign, the diagonal earlobe crease, has been associated with coronary artery disease in more than a dozen published studies since Frank first described it in 1973. The xanthelasma at his eyelids were lipid deposits, extracellular cholesterol that had accumulated in the periorbital dermis, a visible sign of dyslipidemia that his fasting lipid panel alone had not flagged with sufficient urgency (Christoffersen et al., BMJ, 2011).

His dermatologist was not wrong to recommend sunscreen. But she had sent him home without telling him that his skin was saying something his labs were only beginning to say in numbers.

That is the gap this piece intends to close.

What Most Men Hide About Skin

Men do not, as a rule, talk about their skin in clinical terms. They barely talk about it at all until the evidence becomes impossible to ignore.

In male health forums, the conversation tends to emerge sideways, tucked into threads about aging or testosterone or “looking tired all the time”:

“My skin looks ten years older than I feel. I’m 44. People keep asking if I’m tired. I’m not tired. Something has changed in the last two years and I don’t know what it is.” (r/over40fitness)

“I’ve literally never been to a dermatologist. Never thought I needed to. But I’m starting to notice pigmentation on my forehead and my texture is just… rough. Friend of mine who’s the same age looks five years younger and he says he has a skincare routine.” (r/AskMen)

“I’ve been noticing these little yellow bumps near my eyes for a while. Googled it and got xanthelasma. Now I’m reading about cholesterol and I’m not sure whether to panic.” (r/mentalhealth)

What hides inside these threads is something men rarely articulate cleanly: the suspicion that the change in their skin is not cosmetic. That it signals something systemic. That the dermatologist visit, however useful, did not answer the question they were really asking.

The question they are really asking is: what is my skin telling me about what is happening inside?

That is a cardiologist’s question. And the answer, delivered with appropriate precision, is both more reassuring and more urgent than most men expect.

The Mechanism, In Plain English

The skin is not a surface. It is an organ, the largest organ in the body, and like every other organ, it is perfused by microvasculature. The same endothelial function that governs coronary blood flow governs dermal blood flow. The same processes that age the arteries also age the skin. This is not a metaphor or an analogy. It is a shared biological mechanism, and men who understand it will never look at a forehead line the same way again.

Here is the mechanism in four layers.

Layer one: collagen and the androgen connection.

Men’s skin has 20–25% greater initial collagen density than women’s due to androgen-driven fibroblast activity, but loses collagen at the same rate of approximately 1% per year after age 25. This loss accelerates in the 40s when testosterone declines, because androgens directly stimulate fibroblast collagen synthesis. Dermally visible collagen loss in men is therefore a biomarker of testosterone decline, not merely cosmetic aging (Shuster et al., British Journal of Dermatology, 1975).

This is why the men who notice the most dramatic skin change in their mid-forties are often the same men whose testosterone has been quietly declining for five years. The skin is reflecting the hormonal environment. Dermatologists measure it in collagen density. Cardiologists measure it in testosterone levels. They are looking at the same process from different windows.

Layer two: endothelial dysfunction and dermal perfusion.

The skin receives its oxygen and nutrients from a network of dermal capillaries and arterioles that are, like all vascular structures, lined by endothelium. When endothelial dysfunction develops, as it does in men with cardiovascular risk factors, including hypertension, dyslipidemia, insulin resistance, and cigarette exposure, dermal microvascular flow declines. The result is visible: dull, uneven skin tone; slower wound healing; accelerated loss of the plump, hydrated appearance of younger skin.

This is not speculation. Skin microvascular function has been studied as a non-invasive window into systemic vascular health. Studies comparing dermal capillary density and reactive hyperemia in men with and without cardiovascular disease show consistent reduction in men with established endothelial dysfunction (Holowatz and Kenney, Journal of Physiology, 2007).

The skin is the visible end-organ of vascular aging. When endothelial dysfunction reduces dermal microvasculature perfusion, the clinical result includes impaired dermal collagen turnover, reduced skin hydration, accelerated wrinkling, and slowed healing, all of which appear as accelerated skin aging years before cardiovascular symptoms become apparent. The skin is the Vascular Clock made visible.

Layer three: photoaging as an accelerant.

Ultraviolet radiation does something specific to skin that cardiovascular medicine rarely discusses: it directly cleaves collagen and elastin fibers through reactive oxygen species, and it drives inflammation that upregulates matrix metalloproteinases, which are enzymes that actively degrade the extracellular matrix. This is photoaging, and it is additive to the vascular aging happening underneath.

The evidence for topical retinoids (tretinoin, adapalene) in reversing photoaging is among the strongest in all of dermatology: a 1995 landmark trial in the New England Journal of Medicine showed significant reversal of fine wrinkles, pigmentation, and skin texture with tretinoin use over 22 weeks (Griffiths et al., NEJM, 1995). SPF 30 or higher worn daily reduces photoaging progression by approximately 24% over four years compared to sunscreen-use-as-needed (Hughes et al., Annals of Internal Medicine, 2013). These are the two skin interventions with the strongest evidence, and neither requires a prescription internet deep-dive.

Layer four: the visible cardiovascular signs, Frank’s sign and xanthelasma.

These deserve their own conversation because they are, in my clinical experience, among the most underused diagnostic tools in general medicine, and almost entirely absent from consumer health content.

Frank’s sign, the diagonal diagonal crease running from the tragus of the ear across the lobule, was first described by S. T. Frank in 1973 in the New England Journal of Medicine and has since been validated in multiple studies as an independent predictor of coronary artery disease. A 2012 meta-analysis found a pooled odds ratio of approximately 1.6 for coronary artery disease in patients with the sign, independent of age and traditional risk factors (Evrengül et al., Cardiology, 2004).

Xanthelasma, the yellowish lipid plaques that appear at the inner corners of the eyelids, are composed of cholesterol-laden macrophages and are associated with elevated LDL, ApoB, and the small-dense LDL particle pattern most strongly linked to atherosclerotic cardiovascular disease. A Copenhagen City Heart Study analysis of nearly 13,000 subjects found that xanthelasma predicted myocardial infarction, ischemic heart disease, and all-cause mortality independently of plasma cholesterol levels (Christoffersen et al., BMJ, 2011).

No dermatologist will send you to a cardiologist for a forehead line. But a cardiologist looking at your face may see what the skin is trying to say before the standard labs get there.

The Honesty Scale

SDE rates every claim: Solid (1), Promising (2), Early/Theoretical (3–4), Unsupported (5).

• SPF 30+ daily use to slow photoaging: Solid (1), Multiple controlled trials confirm a 24% reduction in photoaging progression with consistent sunscreen use; the effect is biological and documented (Hughes et al., Annals of Internal Medicine, 2013).

• Topical tretinoin (prescription retinoid) for photoaging reversal: Solid (1), Consistent RCT evidence for measurable reversal of fine lines, pigmentation, and texture with use over 6–12 months (Griffiths et al., NEJM, 1995).

• Vitamin C (topical L-ascorbic acid, ≥10%) for collagen stimulation and photoprotection: Promising (2), Multiple small-to-moderate RCTs show reduced hyperpigmentation, improved collagen density, and photoprotection synergism with SPF; formulation stability is a limiting factor for over-the-counter products.

• Oral omega-3 fatty acids for skin barrier function and anti-inflammatory effect: Promising to Early (2–3), Evidence suggests reduced inflammatory skin conditions and improved barrier function; direct impact on wrinkle formation is less well-documented.

• Endothelial dysfunction as driver of accelerated skin aging: Early (3), Mechanistically supported and cross-sectionally demonstrated in vascular disease patients, but prospective intervention trials treating endothelial dysfunction and measuring skin aging outcomes do not yet exist.

• NMN, NAD+ precursors, and peptide serums marketed for “cellular skin renewal”: Theoretical (4), Interesting preclinical mechanisms, negligible human RCT evidence for skin-specific endpoints at commercially available doses.

• Frank’s sign and xanthelasma as cardiovascular risk indicators: Promising (2), Validated in multiple observational studies and one major prospective cohort; not diagnostic alone, but warranting lipid workup and cardiac risk assessment when present.

What the Other Voices Get Wrong

Men’s Health and GQ-style product listicles dominate the first page of search results for “skincare for men over 40.” These lists rank products by brand aesthetic, affiliate revenue, and PR relationships, not evidence. They recommend 8- and 10-step routines, layer multiple active ingredients without noting that some are contraindicated together (for example, vitamin C and niacinamide at low pH can form nicotinic acid), and never once mention that a yellowish deposit near the eye is worth calling your cardiologist about. This is not misinformation precisely. It is the misdirection of attention.

Andrew Huberman has, on multiple occasions, advised against chemical sunscreens and promoted mineral-only options, citing concerns about oxybenzone endocrine disruption. This has been broadly criticized by dermatologists as a misreading of the evidence. The FDA studies he references show oxybenzone systemic absorption but do not show endocrine disruption at the doses achieved through normal sunscreen use. The practical downstream effect of this messaging is that men who trust Huberman’s laboratory credibility on neurochemistry extend that trust to dermatology content that has more nuance than his framing allows, and some of them stop using sunscreen (Huberman Lab, hubermanlab.com). The evidence for daily SPF is Solid (1). Mineral-only recommendations based on absorption concerns are Early (3) at best.

Bryan Johnson’s approach to skin health is the opposite failure mode: it lists the correct interventions, tretinoin, SPF, vitamin C, collagen-supporting nutrition, but buries them inside a 111-compound biohacking framework that signals to men that skin health requires extraordinary complexity and resource (Don’t Die, dontdie.com). The four most evidence-supported interventions in skin aging are not complicated: daily SPF, retinoid three nights per week, consistent sleep, and treating the cardiovascular risk factors that are degrading your dermal microvasculature. A man who waits until he can afford the full Bryan Johnson protocol will wait too long.

Cardiologist’s Note

I want to be direct about what I am and am not saying in this piece.

I am not claiming that skin aging reliably predicts cardiovascular disease, or that good skin means clean arteries, or that treating your skin will treat your heart. The causal arrows here are more nuanced than that.

What I am saying is that skin is an end-organ of vascular aging that is visible in a way the coronary arteries are not. When a man over 45 notices rapid skin change, especially in combination with other metabolic signals, it is reasonable and clinically appropriate to treat that change as a conversation-starter about what is happening systemically, not as a cosmetic problem to manage topically.

Frank’s sign and xanthelasma are not cosmetic issues. If you have either, you should have your ApoB, LDL particle number, and a complete cardiac risk assessment. Full stop.

For men who want the short version of evidence-based skin care: SPF 30 or higher every morning regardless of sun exposure plans. A prescription retinoid at night three times per week. Sleep. And get your fasting lipids checked.

What to Do This Week

These seven actions are sequenced by evidence strength, not by complexity.

1. Buy a broad-spectrum SPF 30 or higher and apply it to your face and neck tomorrow morning. Not mineral vs. chemical. Not high-end vs. drugstore. Any broad-spectrum SPF 30 applied daily is more protective than the best SPF 50 used twice a week. This is the highest-evidence, lowest-cost intervention in skin aging. The evidence is Solid (1) (Hughes et al., Annals of Internal Medicine, 2013).

2. Ask your primary care physician for a prescription for tretinoin 0.025% to 0.05% cream. This is a generic topical retinoid available under $20 at most pharmacies with prescription. Apply three nights per week to a clean, dry face. Expect six weeks of mild dryness and peeling before benefit appears. The evidence for photoaging reversal is among the most robust in all of dermatology.

3. Look at your earlobes with a mirror. A diagonal crease running from the front of the earlobe to the back is Frank’s sign. If you have it, particularly if it is bilateral, tell your physician at your next visit. Ask for an ApoB and a coronary calcium score if you have not had one.

4. Look at your inner upper eyelids. Yellowish plaques or deposits near the inner corners of the eyes are xanthelasma. If you see them, this is a lipid management conversation, not a cosmetic one. Get your lipids checked with ApoB specifically included.

5. Prioritize sleep duration to eight hours. Growth hormone secretion, which is the primary anabolic driver of dermal collagen synthesis, occurs predominantly in deep sleep stages. Chronic short sleep directly impairs collagen turnover. The connection between sleep duration and skin quality is not marketing language. It is biochemistry.

6. Check your testosterone and fasting insulin at next labs. If both are available, they provide a hormonal context for skin change. Testosterone below 400 ng/dL with declining skin quality is a signal worth exploring. Fasting insulin above 15 mIU/L in combination with skin changes suggests the metabolic environment is driving part of the aging signal.

7. Simplify your routine to three products and stay with them for ninety days. SPF. Retinoid. Moisturizer. Any moisturizer. Adding active ingredient after active ingredient without consistent use of any is how men spend money without producing results. Give the foundation time before layering anything.

The Featured Snippet Block

What skin care ingredients do men actually need?

The four ingredients with the strongest clinical evidence in men’s skin aging are: (1) broad-spectrum SPF 30 or higher (Solid/1), the most evidence-supported photoaging prevention tool available; (2) topical tretinoin 0.025–0.1% (Solid/1), demonstrated reversal of fine lines, pigmentation, and texture; (3) topical vitamin C (L-ascorbic acid ≥10%) (Promising/2), collagen stimulation and photoprotection; (4) a simple moisturizer (barrier support). Anything beyond these four requires stronger evidence before ranking as a priority.

Does men’s skin age differently than women’s?

Yes. Men start with 20–25% greater collagen density due to androgen-driven fibroblast activity, so visible aging appears later. However, men lose collagen at the same rate (approximately 1% per year after age 25), and this loss accelerates when testosterone declines in the 40s. When men do begin to show visible aging, it can appear more rapid because it coincides with testosterone decline, endothelial changes, and accumulated photoaging.

When to Call Your Cardiologist

Skin aging, in isolation, is not a cardiac emergency.

The following are reasons to call your cardiologist specifically, not just your dermatologist or primary care physician:

You notice xanthelasma (yellowish deposits near the inner corners of your eyelids) for the first time. You have Frank’s sign (diagonal earlobe crease) and have not had a lipid panel with ApoB in the last two years. Your skin change is accompanied by other metabolic signals: central weight gain, declining energy, elevated blood pressure, or cholesterol numbers trending in the wrong direction.

You are under 55 with accelerating skin change that does not respond to basic topical care. This can be a sign of a systemic inflammatory process, accelerated metabolic aging, or significant vascular risk that deserves clinical evaluation rather than product escalation.

The skin does not lie. It is simply not always easy to read without the right training. The cardiologist’s version of reading it is what I hope this piece has added to your vocabulary.

Close

The man from my opening scene went home that day with a referral letter to his cardiologist for a repeat ApoB and consideration of statin therapy. He also went home with a prescription for tretinoin and a recommendation for daily SPF.

He sent me a message three months later. “I just wanted to let you know I feel strange about the fact that my biggest health wake-up in years came from looking at my face in an examination room mirror.”

That is, I think, exactly the point.

The skin is not the last place vascular aging shows up. For most men, it is among the first. We have just not been in the habit of looking there with clinical eyes.

If this piece has reframed how you see your own skin, the SDE Vascular Clock Starter Kit is the next step. It includes the five biomarkers I use to stage vascular age in men over 40, along with guidance on how to read your own results in clinical context.

The Stop Dying Early newsletter is where I continue this conversation weekly. One email. No product recommendations. Clinical signal only.

IRANA, a word from my Ekegusii inheritance that means to look clearly at what is already in front of you, not to discover something new, but to finally see what was always there.

Your skin has been talking. This piece is the translation.

[Access the Vascular Clock Starter Kit at stopdyingearly.com/starter-kit] [Join the Stop Dying Early newsletter at stopdyingearly.com/newsletter]